Go Pro
→ Your $29.97 book is free today (From Profits Run) (Ad)tc pixel Free AVPT Stock Alerts

AvePoint (AVPT) Financials

AvePoint logo
$13.43 -0.14 (-1.03%)
As of 09/4/2026 04:00 PM Eastern
Compare
Annual Income Statements for AvePoint

Annual Income Statements for AvePoint

This table shows AvePoint's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -128 -51 -68 -42 -22 -29 35
Consolidated Net Income / (Loss)		 -20 -17 -33 -39 -22 -29 35
Net Income / (Loss) Continuing Operations		 -20 -17 -33 -39 -22 -29 35
Total Pre-Tax Income 		-20 -16 -33 -34 -19 -24 41
Total Revenue		 116 152 192 232 272 330 419
Net Interest Income / (Expense)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Income		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Non-Interest Income		 116 152 192 232 272 330 419
Other Non-Interest Income		 116 152 192 232 272 330 419
Total Non-Interest Expense		 135 167 245 273 290 355 379
Marketing Expense		 73 89 133 142 148 172 197
Other Operating Expenses		 61 77 112 131 139 152 190
Other Special Charges		 -0.06 -0.04 - - 3.26 32 -7.47
Income Tax Expense		 0.61 1.06 0.46 5.04 2.89 4.74 5.38
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.03 1.97 2.94 0.22 -0.05 0.32
Basic Earnings per Share		 ($1.72) ($0.57) ($0.48) ($0.23) ($0.12) ($0.16) $0.17
Weighted Average Basic Shares Outstanding		 74.01M 89.64M 141.60M 181.96M 182.26M 183.72M 207.59M
Diluted Earnings per Share		 ($1.72) ($0.57) - - ($0.12) ($0.16) $0.15
Weighted Average Diluted Shares Outstanding		 74.01M 89.64M 182.60M 191.40M 182.26M 183.72M 229.29M
Weighted Average Basic & Diluted Shares Outstanding		 - 9.56M 182.60M 191.40M 184.01M 201.83M 215.47M

Quarterly Income Statements for AvePoint

This table shows AvePoint's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 4.27 -1.72 -13 2.62 -17 3.44 2.70 13 16 15 28
Consolidated Net Income / (Loss)		 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16 15 28
Net Income / (Loss) Continuing Operations		 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16 15 28
Total Pre-Tax Income 		-0.81 0.20 -9.11 3.11 -19 4.87 6.85 13 16 17 12
Total Revenue		 75 75 78 89 89 93 102 110 115 117 124
Net Interest Income / (Expense)		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Income		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Interest Expense		 - 0.00 0.00 0.00 - 0.00 0.00 0.00 - 0.00 0.00
Total Non-Interest Income		 75 75 78 89 89 93 102 110 115 117 124
Other Non-Interest Income		 75 75 78 89 89 93 102 110 115 117 124
Total Non-Interest Expense		 73 74 80 86 83 88 95 97 97 101 112
Marketing Expense		 39 40 43 43 45 47 49 50 51 56 62
Other Operating Expenses		 35 37 37 38 39 43 46 52 49 49 52
Other Special Charges		 - -3.40 - 4.54 - -1.59 0.24 -4.68 - -3.81 -1.79
Income Tax Expense		 -5.25 2.16 3.83 0.18 -1.43 1.31 3.96 -0.21 0.32 1.29 -16
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.17 -0.24 -0.13 0.31 0.01 0.13 0.20 0.00 - 0.00 0.00
Basic Earnings per Share		 $0.02 ($0.01) ($0.07) $0.01 ($0.09) $0.02 $0.01 $0.06 $0.08 $0.07 $0.13
Weighted Average Basic Shares Outstanding		 182.26M 181.50M 182.80M 183.95M 183.72M 197.92M 205.07M 212.00M 207.59M 213.27M 210.20M
Diluted Earnings per Share		 - ($0.01) ($0.07) $0.01 - $0.02 $0.01 $0.06 $0.06 $0.07 $0.12
Weighted Average Diluted Shares Outstanding		 184.01M 181.50M 182.80M 203.86M 201.83M 224.57M 229.18M 232.90M 229.29M 226.11M 220.86M
Weighted Average Basic & Diluted Shares Outstanding		 184.01M 185.29M 186.72M 187.51M 201.83M 203.23M 211.93M 215.79M 215.47M 212.02M 211.57M

Annual Cash Flow Statements for AvePoint

This table details how cash moves in and out of AvePoint's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -4.22 57 199 -41 -4.03 68 190
Net Cash From Operating Activities		 -2.05 19 5.03 -0.77 35 89 85
Net Cash From Continuing Operating Activities		 -2.05 19 5.03 -0.77 35 89 85
Net Income / (Loss) Continuing Operations		 -20 -17 -33 -39 -22 -29 35
Consolidated Net Income / (Loss)		 -20 -17 -33 -39 -22 -29 35
Provision For Loan Losses		 0.30 0.69 - - 0.00 0.00 4.04
Depreciation Expense		 1.05 1.06 1.24 3.49 4.69 5.38 6.21
Non-Cash Adjustments to Reconcile Net Income		 13 33 39 43 54 84 50
Changes in Operating Assets and Liabilities, net		 4.13 1.30 -1.62 -8.27 -2.43 29 -10
Net Cash From Investing Activities		 -1.48 1.37 -3.38 -21 -5.65 -2.60 -20
Net Cash From Continuing Investing Activities		 -1.48 1.37 -3.38 -21 -5.65 -2.60 -20
Purchase of Property, Leasehold Improvements and Equipment		 -1.08 -1.02 -2.46 -5.47 -3.52 -4.26 -5.31
Purchase of Investment Securities		 - 2.39 -0.92 -200 -4.75 -3.57 -15
Sale and/or Maturity of Investments		 -0.40 - 0.00 184 2.62 5.22 0.17
Net Cash From Financing Activities		 -0.09 36 199 -17 -34 -16 124
Net Cash From Continuing Financing Activities		 -0.09 36 199 -17 -34 -16 124
Issuance of Debt		 150 0.28 - - 0.00 0.00 0.00
Repurchase of Common Equity		 0.00 0.00 -108 -20 -39 -37 -50
Other Financing Activities, Net		 -4.68 5.93 437 2.82 5.37 22 174
Effect of Exchange Rate Changes		 -0.59 0.90 -1.17 -1.66 0.60 -3.18 1.28
Cash Interest Paid		 0.00 0.00 4.04 3.32 6.11 6.88 6.83

Quarterly Cash Flow Statements for AvePoint

This table details how cash moves in and out of AvePoint's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 17 -7.67 12 23 41 61 78 42 9.42 -37 -27
Net Cash From Operating Activities		 21 7.76 16 32 33 0.50 20 35 30 24 16
Net Cash From Continuing Operating Activities		 21 7.76 16 32 33 0.50 20 35 30 24 16
Net Income / (Loss) Continuing Operations		 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16 15 28
Consolidated Net Income / (Loss)		 4.44 -1.95 -13 2.93 -17 3.57 2.89 13 16 15 28
Depreciation Expense		 1.25 1.30 1.33 1.40 1.36 1.51 1.62 1.52 1.56 1.66 1.72
Non-Cash Adjustments to Reconcile Net Income		 14 9.75 22 16 36 13 17 8.55 12 8.23 -6.34
Changes in Operating Assets and Liabilities, net		 2.22 -1.34 6.25 12 12 -17 -1.38 7.71 0.40 -0.87 -7.01
Net Cash From Investing Activities		 -1.42 -1.54 -1.05 1.22 -1.23 -17 -13 -0.86 11 -1.60 -1.83
Net Cash From Continuing Investing Activities		 -1.42 -1.54 -1.05 1.22 -1.23 -17 -13 -0.86 11 -1.60 -1.83
Purchase of Property, Leasehold Improvements and Equipment		 -1.06 -0.89 -0.73 -1.63 -1.01 -1.97 -1.33 -0.86 -1.16 -1.71 -1.74
Purchase of Investment Securities		 -1.70 -0.89 -1.27 -1.20 -0.35 -15 -12 -0.14 12 -0.04 -0.09
Net Cash From Financing Activities		 -3.86 -13 -2.86 -12 13 76 71 8.66 -31 -59 -41
Net Cash From Continuing Financing Activities		 -3.86 -13 -2.86 -12 13 76 71 8.66 -31 -59 -41
Repurchase of Common Equity		 -5.39 -14 -5.41 -6.54 -11 -12 -7.05 -8.36 -22 -60 -51
Other Financing Activities, Net		 1.70 0.78 2.55 -5.85 24 88 78 11 -2.97 0.94 9.70
Effect of Exchange Rate Changes		 1.25 -0.93 -0.75 1.77 -3.28 0.93 0.93 -0.81 0.24 -0.71 -0.18
Cash Interest Paid		 0.32 0.98 2.29 2.28 1.33 0.90 1.51 2.29 2.13 2.79 5.82

Annual Balance Sheets for AvePoint

This table presents AvePoint's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 353 169 389 416 443 519 789
Cash and Due from Banks		 0.99 69 268 227 223 291 481
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 - 2.66 3.92 5.54 5.12 5.29 6.02
Deferred Acquisition Cost		 - 32 39 49 55 60 71
Goodwill		 - - 0.00 19 19 18 38
Intangible Assets		 - - 0.00 11 11 8.89 12
Other Assets		 352 65 78 104 130 137 181
Total Liabilities & Shareholders' Equity		 353 169 389 416 443 519 789
Total Liabilities		 35 149 133 172 218 248 310
Short-Term Debt		 0.61 0.77 1.82 1.52 1.38 2.35 3.81
Accrued Interest Payable		 - 26 35 48 54 76 84
Other Short-Term Payables		 0.01 65 74 93 122 144 186
Other Long-Term Liabilities		 34 57 22 30 41 25 37
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 5.00 -193 250 229 219 271 479
Total Preferred & Common Equity		 5.00 -193 250 229 211 269 479
Total Common Equity		 5.00 -193 250 229 211 269 479
Common Stock		 2.03 105 625 666 668 779 980
Retained Earnings		 2.97 -300 -375 -417 -460 -510 -510
Accumulated Other Comprehensive Income / (Loss)		 - 1.79 2.32 2.01 3.20 0.58 8.37

Quarterly Balance Sheets for AvePoint

This table presents AvePoint's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets		 402 399 398 414 427 463 599 700 744 734 757
Cash and Due from Banks		 229 220 206 215 227 250 351 430 472 444 417
Loans and Leases, Net of Allowance		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Premises and Equipment, Net		 5.18 5.00 4.98 4.91 4.52 5.25 5.96 6.22 6.14 6.59 6.80
Deferred Acquisition Cost		 48 49 50 53 52 55 60 63 65 72 74
Goodwill		 19 19 19 19 18 19 37 39 38 37 37
Intangible Assets		 11 11 10 10 9.81 9.71 12 12 12 12 11
Other Assets		 90 95 108 112 116 124 133 150 150 163 211
Total Liabilities & Shareholders' Equity		 402 399 398 414 427 463 599 700 744 734 757
Total Liabilities		 160 173 184 201 220 247 237 257 277 295 320
Short-Term Debt		 1.45 1.44 1.86 7.35 7.46 3.90 2.29 1.81 2.52 4.05 3.31
Accrued Interest Payable		 35 42 45 41 47 57 56 68 83 68 78
Other Short-Term Payables		 91 96 102 115 118 133 150 158 159 189 198
Other Long-Term Liabilities		 32 34 35 38 47 53 29 29 32 35 41
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 227 211 200 213 207 216 361 443 467 439 437
Total Preferred & Common Equity		 227 211 200 211 206 214 360 443 467 439 437
Total Common Equity		 227 211 200 211 206 214 360 443 467 439 437
Common Stock		 675 660 660 678 689 694 873 953 971 964 963
Retained Earnings		 -426 -451 -462 -470 -485 -484 -515 -518 -511 -531 -532
Accumulated Other Comprehensive Income / (Loss)		 2.06 2.25 2.31 2.69 2.73 4.43 1.68 7.62 6.74 6.13 5.68

Annual Metrics And Ratios for AvePoint

This table displays calculated financial ratios and metrics derived from AvePoint's official financial filings.

Metric 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - -
Profitability Metrics		 - - - - - - -
Valuation Ratios		 - - - - - - -
Leverage & Solvency		 - - - - - - -
Liquidity Ratios		 - - - - - - -
Cash Flow Metrics		 - - - - - - -
Efficiency Ratios		 - - - - - - -
Capital & Investment Metrics		 - - - - - - -
Earnings Adjustments		 - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.48) ($0.23) ($0.12) ($0.16) $0.17
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 141.60M 181.96M 182.26M 183.72M 207.59M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.48) $0.00 $0.00 $0.00 $0.15
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 141.60M 191.40M 184.01M 201.83M 229.29M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 182.60M 191.40M 184.01M 201.83M 215.47M
Debt Service Ratios		 - - - - - - -
Payout Ratios		 - - - - - - -

Quarterly Metrics And Ratios for AvePoint

This table displays calculated financial ratios and metrics derived from AvePoint's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 - - - - - - - - - 215,466,019.00 212,017,196.00
DEI Adjusted Shares Outstanding		 - - - - - - - - - 215,466,019.00 212,017,196.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - - 0.07 0.13
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 24.32% 25.12% 20.18% 22.05% 19.51% 24.86% 30.86% 23.56% - 25.98% 22.03%
EBITDA Growth		 119.41% 124.68% 90.00% 414.03% 179.97% 220.29% 1,145.56% 217.72% - 184.96% 62.11%
EBIT Growth		 109.33% 102.82% 76.79% 1,093.93% 334.69% 1,519.21% 420.58% 311.67% - 239.36% 75.24%
NOPAT Growth		 87.94% 61.25% 76.79% 1,436.38% -2,199.75% 223.10% 293.30% 344.57% - 327.65% 852.99%
Net Income Growth		 138.09% 78.72% -3.30% 169.22% -487.24% 282.50% 122.36% 344.57% - 327.65% 852.99%
EPS Growth		 0.00% 0.00% 0.00% 150.00% 0.00% 300.00% 114.29% 500.00% - 250.00% 1,100.00%
Operating Cash Flow Growth		 249.89% 520.48% 101.82% 699.90% 53.01% -93.62% 25.45% 8.11% - 4,801.01% -21.35%
Free Cash Flow Firm Growth		 122.92% 309.24% -44.85% -102.35% -436.13% -782.35% -2,326.06% -32,146.87% - 54.41% 114.23%
Invested Capital Growth		 -7.54% -9.33% -5.16% 1.70% 20.81% 65.27% 107.07% 113.70% - 21.75% -1.07%
Revenue Q/Q Growth		 2.56% -3.71% 4.60% 13.91% 0.43% 4.35% 9.62% 7.56% - 2.23% 6.19%
EBITDA Q/Q Growth		 199.43% -71.08% -154.07% 656.54% 63.09% -34.74% 76.51% 69.12% - -4.83% -24.53%
EBIT Q/Q Growth		 540.26% -94.84% -1,153.20% 245.51% 92.54% -45.13% 108.52% 86.85% - -5.79% -27.37%
NOPAT Q/Q Growth		 -158.47% -245.05% 23.41% 295.64% -544.79% 118.47% 20.27% 349.95% - -2.52% 80.79%
Net Income Q/Q Growth		 204.87% -144.05% -562.13% 122.63% -686.68% 120.76% -18.87% 349.95% - -2.52% 80.79%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -50.00% 500.00% - 16.67% 71.43%
Operating Cash Flow Q/Q Growth		 431.53% -63.77% 108.33% 99.41% 1.68% -98.49% 3,994.95% 71.85% - -18.20% -34.29%
Free Cash Flow Firm Q/Q Growth		 -42.76% 15.78% -50.70% -107.19% -8,087.40% -135.04% -60.84% -4.19% - 67.01% 150.62%
Invested Capital Q/Q Growth		 4.76% -2.71% -2.37% 2.21% 24.44% 33.09% 22.32% 5.48% - -8.22% -0.60%
Profitability Metrics		 - - - - - - - - - - -
EBITDA Margin		 3.52% 2.01% -1.04% 5.08% 8.24% 5.16% 8.30% 13.05% - 15.52% 11.03%
EBIT Margin		 1.85% 0.27% -2.74% 3.50% 6.72% 3.53% 6.72% 11.67% - 14.11% 9.65%
Profit (Net Income) Margin		 5.94% -2.62% -16.60% 3.30% -19.26% 3.83% 2.84% 11.86% - 13.01% 22.15%
Tax Burden Percent		 -548.33% -962.56% 142.05% 94.12% 92.33% 73.18% 42.21% 101.64% - 92.22% 229.54%
Interest Burden Percent		 -58.71% 100.00% 426.01% 100.00% -310.60% 148.25% 100.00% 100.00% - 100.00% 100.00%
Effective Tax Rate		 0.00% 1,062.56% 0.00% 5.88% 0.00% 26.82% 57.79% -1.64% - 7.78% -129.54%
Return on Invested Capital (ROIC)		 -0.88% -3.25% -2.61% 4.78% -19.32% 3.09% 3.21% 13.57% - 14.31% 23.33%
ROIC Less NNEP Spread (ROIC-NNEP)		 343.75% -3.25% -259.69% 4.78% -241.73% 27.17% 3.21% 13.57% - 14.31% 23.33%
Return on Net Nonoperating Assets (RNNOA)		 2.13% -0.06% -5.34% 0.06% -1.82% 0.46% 0.05% 0.13% - 0.11% 0.14%
Return on Equity (ROE)		 1.26% -3.31% -7.95% 4.85% -21.14% 3.55% 3.25% 13.70% - 14.42% 23.46%
Cash Return on Invested Capital (CROIC)		 3.27% 6.40% 1.78% -3.80% -16.84% -53.94% -70.54% -71.82% - -8.01% 17.23%
Operating Return on Assets (OROA)		 1.17% 0.19% -1.99% 2.57% 4.62% 2.43% 4.45% 7.62% - 9.39% 6.17%
Return on Assets (ROA)		 3.77% -1.84% -12.05% 2.42% -13.24% 2.64% 1.88% 7.75% - 8.66% 14.17%
Return on Common Equity (ROCE)		 1.18% -3.20% -7.67% 4.67% -20.46% 3.52% 3.25% 13.66% - 14.39% 23.46%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -6.76% -7.13% -3.52% 0.00% -6.57% -1.76% 0.49% - 10.67% 16.36%
Net Operating Profit after Tax (NOPAT)		 -0.57 -1.95 -1.50 2.93 -13 2.41 2.89 13 - 15 28
NOPAT Margin		 -0.76% -2.62% -1.92% 3.30% -14.60% 2.58% 2.84% 11.86% - 13.01% 22.15%
Net Nonoperating Expense Percent (NNEP)		 -344.63% 0.00% 257.08% 0.00% 222.40% -24.08% 0.00% 0.00% - 0.00% 0.00%
SG&A Expenses to Revenue		 51.64% 54.24% 55.12% 48.30% 50.77% 50.73% 47.77% 45.14% - 47.57% 49.89%
Operating Expenses to Revenue		 98.15% 99.73% 102.74% 96.50% 93.28% 96.47% 93.28% 88.33% - 85.90% 90.35%
Earnings before Interest and Taxes (EBIT)		 1.38 0.20 -2.14 3.11 5.99 3.29 6.85 13 - 17 12
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2.63 1.50 -0.81 4.51 7.35 4.80 8.47 14 - 18 14
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.16 6.90 9.38 10.28 11.50 8.11 8.86 6.81 - 4.67 5.44
Price to Tangible Book Value (P/TBV)		 8.34 8.00 10.87 11.87 12.76 9.36 9.99 7.64 - 5.25 6.11
Price to Revenue (P/Rev)		 5.55 5.08 6.44 6.96 9.37 8.35 10.52 8.07 - 4.62 5.10
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1,614.73 - 43.96 33.25
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% - 2.27% 3.01%
Enterprise Value to Invested Capital (EV/IC)		 5.75 5.68 7.97 8.90 10.28 7.06 7.86 5.78 - 3.63 4.46
Enterprise Value to Revenue (EV/Rev)		 4.78 4.36 5.71 6.18 8.50 7.36 9.37 6.88 - 3.63 4.21
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 408.66 249.78 223.88 161.99 139.15 77.61 - 27.50 30.78
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 764.98 392.02 250.46 181.71 93.71 - 30.84 34.24
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 560.03 0.00 0.00 1,180.11 - 34.38 27.46
Enterprise Value to Operating Cash Flow (EV/OCF)		 37.48 30.36 34.70 25.20 31.60 31.45 40.78 30.69 - 14.76 18.75
Enterprise Value to Free Cash Flow (EV/FCFF)		 168.89 84.47 435.81 0.00 0.00 0.00 0.00 0.00 - 0.00 25.75
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.01 0.03 0.04 0.02 0.01 0.01 0.00 0.01 - 0.01 0.01
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Financial Leverage		 0.01 0.02 0.02 0.01 0.01 0.02 0.01 0.01 - 0.01 0.01
Leverage Ratio		 1.83 1.80 1.91 2.00 1.94 1.76 1.73 1.77 - 1.67 1.66
Compound Leverage Factor		 -1.08 1.80 8.13 2.00 -6.02 2.61 1.73 1.77 - 1.67 1.66
Debt to Total Capital		 0.61% 3.34% 3.47% 1.77% 0.86% 0.63% 0.41% 0.54% - 0.91% 0.75%
Short-Term Debt to Total Capital		 0.61% 3.34% 3.47% 1.77% 0.86% 0.63% 0.41% 0.54% - 0.91% 0.75%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Noncontrolling Interests to Total Capital		 6.30% 0.74% 0.70% 0.87% 0.66% 0.54% 0.00% 0.00% - 0.00% 0.00%
Common Equity to Total Capital		 93.09% 95.92% 95.83% 97.36% 98.48% 98.83% 99.59% 99.46% - 99.09% 99.25%
Debt to EBITDA		 -0.13 -2.37 1.78 0.50 0.19 0.14 0.07 0.07 - 0.07 0.05
Net Debt to EBITDA		 20.80 67.23 -52.38 -31.44 -22.98 -22.03 -17.03 -13.43 - -7.52 -6.49
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Debt to NOPAT		 -0.13 -0.94 -0.96 -0.84 0.47 -0.17 -0.68 1.10 - 0.09 0.05
Net Debt to NOPAT		 20.64 26.53 28.25 53.20 -57.49 25.28 162.32 -204.14 - -9.40 -5.79
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Noncontrolling Interest Sharing Ratio		 6.04% 3.45% 3.58% 3.70% 3.24% 0.62% 0.23% 0.28% - 0.24% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 18 21 10 -0.73 -60 -141 -227 -237 - -64 32
Operating Cash Flow to CapEx		 2,029.38% 868.53% 2,207.38% 1,982.77% 3,259.70% 25.18% 1,529.81% 4,064.53% - 1,419.54% 916.21%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.63 0.70 0.73 0.73 0.69 0.69 0.66 0.65 - 0.67 0.64
Fixed Asset Turnover		 51.02 56.89 63.01 61.76 63.51 64.23 69.43 69.19 - 70.68 71.61
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 226 220 215 220 273 364 445 469 - 443 440
Invested Capital Turnover		 1.15 1.24 1.36 1.45 1.32 1.20 1.13 1.14 - 1.10 1.05
Increase / (Decrease) in Invested Capital		 -18 -23 -12 3.66 47 144 230 250 - 79 -4.75
Enterprise Value (EV)		 1,300 1,251 1,713 1,954 2,809 2,567 3,496 2,712 - 1,609 1,963
Market Capitalization		 1,508 1,457 1,931 2,198 3,096 2,914 3,924 3,181 - 2,049 2,377
Book Value per Share		 $1.15 $1.15 $1.11 $1.15 $1.44 $1.78 $2.18 $2.20 - $2.04 $2.06
Tangible Book Value per Share		 $0.98 $0.99 $0.96 $0.99 $1.29 $1.54 $1.93 $1.97 - $1.81 $1.83
Total Capital		 226 220 215 220 273 364 445 469 - 443 440
Total Debt		 1.38 7.35 7.46 3.90 2.35 2.29 1.81 2.52 - 4.05 3.31
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Net Debt		 -222 -208 -220 -246 -288 -349 -428 -469 - -440 -414
Capital Expenditures (CapEx)		 1.06 0.89 0.73 1.63 1.01 1.97 1.33 0.86 - 1.71 1.74
Net Nonoperating Expense (NNE)		 -5.00 0.00 11 0.00 4.15 -1.16 0.00 0.00 - 0.00 0.00
Net Nonoperating Obligations (NNO)		 1.38 7.35 7.46 3.90 2.35 2.29 1.81 2.52 - 4.05 3.31
Total Depreciation and Amortization (D&A)		 1.25 1.30 1.33 1.40 1.36 1.51 1.62 1.52 - 1.66 1.72
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.02 ($0.01) ($0.07) $0.01 ($0.09) $0.02 $0.01 $0.06 $0.08 $0.07 $0.13
Adjusted Weighted Average Basic Shares Outstanding		 182.26M 181.50M 182.80M 183.95M 183.72M 197.92M 205.07M 212.00M 207.59M 213.27M 210.20M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.01 $0.00 $0.02 $0.01 $0.06 $0.06 $0.07 $0.12
Adjusted Weighted Average Diluted Shares Outstanding		 184.01M 185.29M 186.72M 203.86M 201.83M 224.57M 229.18M 232.90M 229.29M 226.11M 220.86M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 184.01M 185.29M 186.72M 187.51M 201.83M 203.23M 211.93M 215.79M 215.47M 212.02M 211.57M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.57 -2.24 -1.50 7.20 -13 2.41 4.97 5.69 - 12 7.16
Normalized NOPAT Margin		 -0.76% -3.01% -1.92% 8.11% -14.60% 2.58% 4.87% 5.19% - 10.01% 5.75%
Pre Tax Income Margin		 -1.08% 0.27% -11.68% 3.50% -20.86% 5.24% 6.72% 11.67% - 14.11% 9.65%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00% 0.00%
Augmented Payout Ratio		 -181.55% -357.09% -280.42% -412.95% -127.12% -149.04% -472.94% 1,682.25% - 208.64% 197.42%

Financials Breakdown Chart

Key Financial Trends

AvePoint’s financial profile has improved meaningfully from late 2022 through the second quarter of 2026. Revenue increased from $63.7 million in Q3 2022 to $124.5 million in Q2 2026, representing nearly a 96% increase. Growth has been consistent, with revenue rising in each comparable quarter from Q2 2023 through Q2 2026.

Profitability has also improved. AvePoint reported a $27.6 million net profit in Q2 2026, compared with a $2.9 million profit in the restated Q2 2025 results and losses in several 2023 and 2024 quarters. However, the latest net income benefited substantially from a reported $15.6 million income-tax benefit, so investors should focus on whether operating profitability continues to improve independently of tax-related items.

Cash generation remains positive, although recent share repurchases have significantly reduced cash balances. AvePoint generated $15.9 million of operating cash flow in Q2 2026, while ending the quarter with $417.3 million in cash and equivalents. The company’s balance sheet shows low short-term debt but substantial accrued liabilities and negative retained earnings.

  • Sustained revenue growth: Quarterly revenue climbed from $59.6 million in Q1 2023 to $124.5 million in Q2 2026. Q2 2026 revenue increased approximately 6.2% sequentially and 22.0% from the restated Q2 2025 level.
  • Improving operating leverage: Total non-interest expenses grew more slowly than revenue in Q2 2026. Expenses represented about 90.4% of revenue, compared with approximately 93.3% in Q2 2025, helping lift the pretax margin to roughly 9.6% from 6.7%.
  • Return to stronger profitability: Net income attributable to common shareholders rose to $27.6 million in Q2 2026 from $15.3 million in Q1 2026 and $2.7 million in restated Q2 2025. Basic EPS increased to $0.13 from $0.07 in Q1 2026.
  • Positive operating cash flow: Operating cash flow has remained positive in every quarter provided, including $15.9 million in Q2 2026. This indicates that the business is producing cash even though reported earnings have historically been uneven.
  • Strong liquidity and limited debt: AvePoint held $417.3 million of cash and equivalents at June 30, 2026, compared with only $3.3 million of short-term debt. Cash was also substantially higher than the $249.8 million reported at September 30, 2024.
  • Capital allocation is heavily weighted toward buybacks: AvePoint repurchased $50.5 million of common stock in Q2 2026 after spending $59.8 million in Q1. Buybacks can support per-share value, but they also explain much of the recent decline in cash and may limit funds available for acquisitions or internal investment.
  • Asset growth includes significant acquisition-related balances: Deferred acquisition costs, goodwill and intangible assets totaled approximately $122.6 million at June 30, 2026. These balances can support future growth, but they also create exposure to impairment charges if acquired businesses underperform.
  • Cash declined despite positive operating cash flow: Cash and equivalents fell from $444.1 million in Q1 2026 to $417.3 million in Q2. The $26.9 million quarterly decrease occurred primarily because financing outflows, including share repurchases, exceeded operating cash generation.
  • Large accumulated deficit: Retained earnings were negative $531.7 million at the end of Q2 2026. Although current earnings have improved, AvePoint has not yet eliminated the sizable cumulative deficit built up over prior years.
  • Liabilities and dilution require monitoring: Total liabilities increased to $320.1 million from $237.4 million at the end of Q3 2024, with other short-term payables and accrued interest payable making up most of the balance. In addition, Q2 2026 diluted weighted-average shares exceeded basic shares by roughly 10.7 million, limiting the benefit of earnings growth for existing shareholders.

Overall, AvePoint is showing a favorable growth and profitability trend, supported by strong liquidity and positive operating cash flow. The main risks are the pace of cash consumption from buybacks, substantial payables, acquisition-related assets, persistent negative retained earnings and dilution. Investors should also treat quarter-to-quarter earnings comparisons cautiously because several historical statements were restated and the Q2 2026 tax benefit had a significant effect on reported net income.

09/05/26 04:09 AM ETAI Generated. May Contain Errors.

AvePoint Financials - Frequently Asked Questions

According to the most recent income statement we have on file, AvePoint's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

AvePoint's net income appears to be on a downward trend, with a most recent value of $35.12 million in 2025, falling from -$20.17 million in 2019. The previous period was -$29.14 million in 2024. See AvePoint's forecast for analyst expectations on what's next for the company.

Over the last 6 years, AvePoint's total revenue changed from $116.10 million in 2019 to $419.50 million in 2025, a change of 261.3%.

AvePoint's total liabilities were at $310.48 million at the end of 2025, a 25.1% increase from 2024, and a 794.4% increase since 2019.

In the past 6 years, AvePoint's cash and equivalents has ranged from $994.81 thousand in 2019 to $481.06 million in 2025, and is currently $481.06 million as of their latest financial filing in 2025.


Related Companies

Financial statements for NASDAQ:AVPT last updated on 8/6/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel